The mR18L peptide also reduced plasma cholesterol concentration in LDLR-null mice as efficiently as Ac-hE18A-NH2 but was less effective in reducing atherosclerosis than Ac-hE18A-NH2 [89]. This evidence concerns the gene LDLR and atherosclerosis.